May 31, 2016

Amicus Therapeutics Announces European Commission Approval for Galafold™ (Migalastat) in Patients with Fabry Disease in European Union

May 5, 2016

Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

May 3, 2016

Amicus Therapeutics Announces First Quarter 2016 Financial Results and Corporate Updates